1-deoxynojirimycin has been researched along with lamivudine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Block, TM; Lu, X; Mehta, AS; Ouzounov, S; Simsek, E | 1 |
1 other study(ies) available for 1-deoxynojirimycin and lamivudine
Article | Year |
---|---|
alpha-Glucosidase inhibitors have a prolonged antiviral effect against hepatitis B virus through the sustained inhibition of the large and middle envelope glycoproteins.
Topics: 1-Deoxynojirimycin; Antiviral Agents; Cell Line, Tumor; Cell Survival; DNA, Viral; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glycoproteins; Glycoside Hydrolase Inhibitors; Hepatitis B virus; Humans; Lamivudine; Microbial Sensitivity Tests; Structure-Activity Relationship; Tumor Cells, Cultured; Viral Envelope Proteins | 2006 |